Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6438 | 1418 | 33.6 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
126 | 23061 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//MYCOPHENOLIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYP3A5 | Author keyword | 145 | 58% | 12% | 168 |
2 | TACROLIMUS | Author keyword | 84 | 17% | 33% | 462 |
3 | CYTOCHROME P450 3A5 | Author keyword | 19 | 71% | 1% | 15 |
4 | CYP3A422 | Author keyword | 18 | 83% | 1% | 10 |
5 | CYP3A53 | Author keyword | 15 | 62% | 1% | 16 |
6 | CYP3A41B | Author keyword | 14 | 100% | 0% | 7 |
7 | TACROLIMUS PHARMACOKINETICS | Author keyword | 13 | 80% | 1% | 8 |
8 | CYP3A418B | Author keyword | 12 | 86% | 0% | 6 |
9 | RS35599367 | Author keyword | 11 | 100% | 0% | 6 |
10 | ACMIA | Author keyword | 10 | 73% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP3A5 | 145 | 58% | 12% | 168 | Search CYP3A5 | Search CYP3A5 |
2 | TACROLIMUS | 84 | 17% | 33% | 462 | Search TACROLIMUS | Search TACROLIMUS |
3 | CYTOCHROME P450 3A5 | 19 | 71% | 1% | 15 | Search CYTOCHROME+P450+3A5 | Search CYTOCHROME+P450+3A5 |
4 | CYP3A422 | 18 | 83% | 1% | 10 | Search CYP3A422 | Search CYP3A422 |
5 | CYP3A53 | 15 | 62% | 1% | 16 | Search CYP3A53 | Search CYP3A53 |
6 | CYP3A41B | 14 | 100% | 0% | 7 | Search CYP3A41B | Search CYP3A41B |
7 | TACROLIMUS PHARMACOKINETICS | 13 | 80% | 1% | 8 | Search TACROLIMUS+PHARMACOKINETICS | Search TACROLIMUS+PHARMACOKINETICS |
8 | CYP3A418B | 12 | 86% | 0% | 6 | Search CYP3A418B | Search CYP3A418B |
9 | RS35599367 | 11 | 100% | 0% | 6 | Search RS35599367 | Search RS35599367 |
10 | ACMIA | 10 | 73% | 1% | 8 | Search ACMIA | Search ACMIA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYP3A5 | 94 | 54% | 9% | 121 |
2 | MDR1 ABCB1 POLYMORPHISMS | 65 | 85% | 2% | 34 |
3 | CYTOCHROME P4503A5 | 60 | 100% | 1% | 20 |
4 | ABCB1 POLYMORPHISMS | 55 | 67% | 3% | 49 |
5 | TACROLIMUS DOSE REQUIREMENTS | 51 | 79% | 2% | 33 |
6 | CYP3A5 GENOTYPE | 38 | 64% | 3% | 37 |
7 | MICROPARTICLE ENZYME IMMUNOASSAY | 32 | 56% | 3% | 39 |
8 | APPARENT CLEARANCE | 30 | 100% | 1% | 12 |
9 | DOSE REQUIREMENTS | 26 | 26% | 6% | 84 |
10 | FK 506 ASSAY | 21 | 75% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I | 2010 | 114 | 129 | 73% |
The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation | 2014 | 18 | 165 | 65% |
Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics | 2007 | 85 | 26 | 88% |
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy | 2013 | 20 | 79 | 70% |
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference | 2009 | 136 | 104 | 55% |
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II | 2010 | 69 | 66 | 52% |
Functional Gene Variants of CYP3A4 | 2014 | 5 | 69 | 72% |
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation | 2004 | 245 | 270 | 54% |
Significance of the minor cytochrome P450 3A isoforms | 2006 | 118 | 115 | 54% |
Genetic contribution to variable human CYP3A-mediated metabolism | 2002 | 505 | 102 | 34% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IND ENVIRONM TOXICOL UNIT | 9 | 83% | 0.4% | 5 |
2 | CARDIAC VASC SCI ANALYT UNIT | 6 | 100% | 0.3% | 4 |
3 | ABSORPT DIGEST | 4 | 75% | 0.2% | 3 |
4 | UNIDAD FARMACOGENET | 4 | 56% | 0.4% | 5 |
5 | UMR S490 | 3 | 57% | 0.3% | 4 |
6 | SECT PHARMACOL P BENIGNO | 3 | 60% | 0.2% | 3 |
7 | UMR S 850 | 3 | 60% | 0.2% | 3 |
8 | TOXICOL THER EUT DRUG MONITORING | 2 | 44% | 0.3% | 4 |
9 | BIOL CELULAR ENFERMEDAD RENAL | 2 | 67% | 0.1% | 2 |
10 | CHEM MEASUREMENT CALIBRAT | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000240241 | FK 506//FUJISAWA AMER//FUJISAWA AMER INC |
2 | 0.0000175133 | NEORAL//C2 MONITORING//C 2 MONITORING |
3 | 0.0000133308 | CYP3A//COCKTAIL//MECHANISM BASED INHIBITION |
4 | 0.0000113970 | P GLYCOPROTEIN//C3435T POLYMORPHISM//ABCB1 |
5 | 0.0000104232 | SIROLIMUS//EVEROLIMUS//PROLIFERATION SIGNAL INHIBITORS |
6 | 0.0000097454 | RHEUMATOLOTA KU//MDR I//DANINI HOSP |
7 | 0.0000094750 | MYCOPHENOLIC ACID//MYCOPHENOLIC ACID GLUCURONIDE//MYCOPHENOLATE MOFETIL |
8 | 0.0000092385 | IMMUKNOW//IMMUNE FUNCTION ASSAY//CYLEX IMMUKNOW ASSAY |
9 | 0.0000090084 | ONCE DAILY TACROLIMUS//TACROLIMUS ONCE DAILY//SECT NEPHROL HYPERTENS TRANSPLANTAT MED |
10 | 0.0000062060 | CYCLOSPORINE G//CYCLOSPORINE METABOLITES//CYCLOSPORIN G |